Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7
Frequently Asked Questions
What is Market Cap of Traws Pharma Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Traws Pharma Inc. market cap is $12.96M.
What is the 52-week high for Traws Pharma Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Traws Pharma Inc. 52 week high is $19.44 as of September 12, 2025.
What is the 52-week low for Traws Pharma Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Traws Pharma Inc. 52 week low is $0.97 as of September 12, 2025.
What is Traws Pharma Inc. stock price today?
Traws Pharma Inc. stock price today is $1.81.
What was Traws Pharma Inc. stock price yesterday?
Traws Pharma Inc. stock price yesterday was $1.84.
What is the PE ratio of Traws Pharma Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Traws Pharma Inc.’s P/E ratio is 0.12.
What is the Price-to-Book ratio of Traws Pharma Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Traws Pharma Inc. P/B ratio is 1.5701.
What is the 50-day moving average of Traws Pharma Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Traws Pharma Inc. 50-day moving average is $1.55.